Insufficient scRNA-seq data for expression of NAB2 at single-cell level.
Insufficient scRNA-seq data for expression of NAB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 4281.68 | 1808 / 1809 | 100% | 86.94 | 472 / 472 |
ovary | 100% | 6058.53 | 180 / 180 | 100% | 82.43 | 429 / 430 |
uterus | 100% | 4870.16 | 170 / 170 | 99% | 66.02 | 455 / 459 |
thymus | 100% | 2832.60 | 653 / 653 | 99% | 155.60 | 598 / 605 |
prostate | 100% | 3381.50 | 245 / 245 | 97% | 28.63 | 486 / 502 |
breast | 98% | 1905.90 | 450 / 459 | 97% | 42.28 | 1088 / 1118 |
lung | 100% | 3069.26 | 577 / 578 | 95% | 54.95 | 1103 / 1155 |
esophagus | 100% | 2949.16 | 1445 / 1445 | 95% | 35.79 | 173 / 183 |
adrenal gland | 100% | 1832.76 | 258 / 258 | 94% | 46.10 | 217 / 230 |
brain | 94% | 2651.35 | 2496 / 2642 | 100% | 45.60 | 703 / 705 |
kidney | 100% | 2200.04 | 89 / 89 | 93% | 36.98 | 842 / 901 |
bladder | 100% | 3503.76 | 21 / 21 | 89% | 34.24 | 451 / 504 |
liver | 96% | 1325.16 | 216 / 226 | 80% | 20.26 | 323 / 406 |
intestine | 96% | 2672.61 | 925 / 966 | 76% | 18.04 | 400 / 527 |
stomach | 89% | 1611.04 | 320 / 359 | 81% | 19.45 | 232 / 286 |
pancreas | 26% | 211.66 | 85 / 328 | 96% | 40.47 | 171 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 63.86 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 41.62 | 29 / 29 |
spleen | 100% | 2116.70 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 61.76 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 39.70 | 1 / 1 |
blood vessel | 100% | 3974.87 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 2250.92 | 1194 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 1444.76 | 833 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 42% | 815.19 | 389 / 929 | 0% | 0 | 0 / 0 |
muscle | 36% | 335.20 | 291 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016480 | Biological process | negative regulation of transcription by RNA polymerase III |
GO_0014037 | Biological process | Schwann cell differentiation |
GO_0001958 | Biological process | endochondral ossification |
GO_0042552 | Biological process | myelination |
GO_0045682 | Biological process | regulation of epidermis development |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0003712 | Molecular function | transcription coregulator activity |
Gene name | NAB2 |
Protein name | NGFI-A-binding protein 2 (EGR-1-binding protein 2) (Melanoma-associated delayed early response protein) (Protein MADER) |
Synonyms | MADER |
Description | FUNCTION: Acts as a transcriptional repressor for zinc finger transcription factors EGR1 and EGR2. Isoform 2 lacks repression ability (By similarity). . |
Accessions | Q15742 ENST00000342556.6 [Q15742-3] ENST00000300131.8 [Q15742-1] |